Featured Research

from universities, journals, and other organizations

Smallpox: Scourge, Weapon, Research Tool -- Complexities Of A Global Policy

Date:
July 16, 1999
Source:
University Of Florida Health Science Center
Summary:
A UF Institute for Science and Health Policy-hosted forum featuring experts who will discuss the significant global issues surrounding whether or not the remaining vials of the deadly smallpox virus should be destroyed.

What: A UF Institute for Science and Health Policy-hosted forum featuring experts who will discuss the significant global issues surrounding whether or not the remaining vials of the deadly smallpox virus should be destroyed.

When: 4 p.m., Monday, July 19, 1999

Via Internet: Seminar will be accessible through a live Webcast, which can be linked through http://www.health.ufl.edu/hscc.

Four experts in the field of virology will participate in the forum:

D.A. Henderson, M.D., M.P.H., a leading advocate of destroying the virus. Henderson is a distinguished service professor in the departments of epidemiology and international health at Johns Hopkins University's School of Hygiene and Public Health;

Kenneth Bernard, M.D., U.S. representative to the World Health Organization and the U.S. Department of Health and Human Services' liaison to the National Security Council;

Kenneth I. Berns, M.D., Ph.D., dean of UF's College of Medicine, interim vice president for health affairs, and member of the national advisory panel charged with reviewing whether or not potential scientific opportunities would be lost if the last remaining vials of the virus were destroyed. Organized by the National Academy of Sciences' Institute of Medicine at the request of the White House, the panel recently briefed the president on the issue;

Richard W. Moyer, Ph.D., chairman of the UF College of Medicine's department of molecular genetics and microbiology, and member of the Institute of Medicine's national advisory panel.


Story Source:

The above story is based on materials provided by University Of Florida Health Science Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Florida Health Science Center. "Smallpox: Scourge, Weapon, Research Tool -- Complexities Of A Global Policy." ScienceDaily. ScienceDaily, 16 July 1999. <www.sciencedaily.com/releases/1999/07/990715105815.htm>.
University Of Florida Health Science Center. (1999, July 16). Smallpox: Scourge, Weapon, Research Tool -- Complexities Of A Global Policy. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/1999/07/990715105815.htm
University Of Florida Health Science Center. "Smallpox: Scourge, Weapon, Research Tool -- Complexities Of A Global Policy." ScienceDaily. www.sciencedaily.com/releases/1999/07/990715105815.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins